PubMed

Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes.

Kelley DE, Kuller LH, McKolanis TM, Harper P, Mancino J, Kalhan S.

Diabetes Care. 2004 Jan;27(1):33-40.PMID: 14693963 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.PMID: 10937514 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671.. PMID: 12087008 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.PMID: 12681025 [PubMed - indexed for MEDLINE]Related articles

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.

Berne C; Orlistat Swedish Type 2 diabetes Study Group.

Diabet Med. 2005 May;22(5):612-8.PMID: 15842517 [PubMed - indexed for MEDLINE]Related articles

The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.

Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ.

Diabetes Care. 1998 May;21(5):687-94.PMID: 9589225 [PubMed - indexed for MEDLINE]Related articlesFree article

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.

Shi YF, Pan CY, Hill J, Gao Y.

Diabet Med. 2005 Dec;22(12):1737-43.PMID: 16401321 [PubMed - indexed for MEDLINE]Related articles

Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.

Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.

Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7.PMID: 11477493 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, So WY, Ma RC, Ozaki R, Woo J, Cockram CS, Chan JC.

Arch Intern Med. 2002 Nov 25;162(21):2428-35.PMID: 12437401 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA.

J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91.PMID: 12050251 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.

Hanefeld M, Sachse G.

Diabetes Obes Metab. 2002 Nov;4(6):415-23.PMID: 12406041 [PubMed - indexed for MEDLINE]Related articles

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.

Tan KC, Tso AW, Tam SC, Pang RW, Lam KS.

Diabet Med. 2002 Nov;19(11):944-8.PMID: 12421432 [PubMed - indexed for MEDLINE]Related articles

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults.

Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JP, Sjöström L.

Arch Intern Med. 2000 May 8;160(9):1321-6.PMID: 10809036 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.

Tiikkainen M, Bergholm R, Rissanen A, Aro A, Salminen I, Tamminen M, Teramo K, Yki-Järvinen H.

Am J Clin Nutr. 2004 Jan;79(1):22-30.PMID: 14684393 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.

Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC.

Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E906-16.PMID: 12959938 [PubMed - indexed for MEDLINE]Related articlesFree article